Early Access — free while we kick the tires
EdgarHawk

Jeffrey A Stopko

President & CEO ASRV & Bank

Officer

Latest: President & CEO ASRV & Bank buying · May 2026

8 filings analyzed · 1 company · Latest 2026-05-06

Companies

Company Buys Sells Direction
AMERISERV FINANCIAL INC /PA/ ASRV 10 0 Net buying

Activity

May 2026
high
Buy
3,000 shares
$11,550
Significance 7/10

ASRV CEO Jeffrey Stopko buys 3,000 shares at market; stock trading below recent highs, company remains profitable

Jeffrey Stopko, President and CEO of AmeriServ Financial, purchased shares at market prices while the stock trades noticeably below its recent highs—a classic setup where insider buying carries more weight because it's happening during weakness, not momentum. The company maintains profitability with reasonable valuation, suggesting Stopko is buying a fundamentally sound business rather than chasing a turnaround. A CEO committing personal capital at a moment when the stock has retreated from recent peaks demonstrates conviction in the company's near-term prospects. This is the kind of open-market purchase that retail investors track because it represents direct alignment between Stopko's personal interests and shareholder returns—he's not exercising options or receiving restricted shares, but spending real money at current market prices.

September 2025
medium
Buy
2,000 shares
$5,727
Significance 5/10

ASRV CEO Jeffrey Stopko buys 2,000 shares in 2 transactions for $5,726.85 at blended average $2.86, holding rises to 162,000 shares.

Jeffrey A Stopko, President & CEO of AMERISERV FINANCIAL, executed 2 separate open-market purchases totaling 2,000 shares for $5,726.85, increasing his holdings by 1.2% to 162,000 shares. The shares were purchased at prices ($2.85 and $2.89) near current price ($2.87) during a period when the stock stands -13.0% from its 52-week high of $3.30. Stopko's prior trades at ASRV show mixed near-term outcomes (4 of 5 measurable trades within the past 12 months), though his cross-ticker track record reflects a 61.54% 90-day win rate. The company currently reports negative net income ($-282,000.00 in the latest quarter) alongside modest revenue growth (+7.8% annual) and a P/E of 13.05, providing limited fundamental tailwinds to offset the stock's recent weakness.

August 2025
medium
Buy
3,000 shares
$9,120
Significance 5/10

ASRV President & CEO Stopko buys 3,000 shares at $3.04; holds 160,000 post-transaction as stock trades -9.7% from 52-week high.

Jeffrey A. Stopko, President & CEO of Ameriserv Financial, purchased 3,000 shares at $3.04 on 2025-08-28, bringing his total holdings to 160,000 shares. The purchase occurs as the stock trades at $2.98, down 9.7% from its 52-week high of $3.30, though up 6.4% over the past 30 days and 6.0% over 90 days. Stopko's prior trades at ASRV show mixed timing outcomes: 3 of 5 prior buys were well-timed at the 90-day mark, with two achieving substantial gains (+21.1% and +22.3%), but two resulted in losses (-6.9% and -3.5%), indicating variability in execution rather than a consistent pattern. The company's fundamentals show revenue of $3.6M in the latest quarter against a net loss of $-282.0K, with annual revenue growth of +7.8% and a market cap of $49.2M. This buy represents a modest 1.9% increase to his holdings and warrants monitoring to assess whether this near-trough purchase aligns with the insider's prior buy timing patterns at this ticker.

March 2025
medium
Buy
3,000 shares
$7,260
Significance 5/10

ASRV CEO Stopko buys 3,000 shares at $2.42; stock down 19.4% from 52-week high and -1.7% YoY revenue, full-year unprofitable.

President & CEO Jeffrey A. Stopko purchased 3,000 shares at $2.42 on 2025-03-13, adding to his 157,000-share position and marking his sixth open-market transaction at ASRV in seven months. At the current price of $2.45, the stock is -19.4% from its 52-week high and down 14.9% over 90 days, while the company reported full-year net income negative and annual revenue decline of -1.7%. His prior four trades at this ticker show a timing pattern of 75% well-timed at the 90-day mark (3 of 4 measurable), though his most recent buy on 2025-02-03 has returned -5.0% over 30 days. The CEO's repeated accumulation despite fundamental deterioration and ongoing stock weakness presents a factual signal worth monitoring against near-term price action and quarterly results.

February 2025
medium
Buy
3,000 shares
$7,860
Significance 6/10

CEO Jeffrey Stopko buys 3,000 ASRV shares at $2.62; extends pattern of 4 prior well-timed buys at ticker despite -15.0% distance from 52-week high.

Jeffrey Stopko, President & CEO, purchased 3,000 shares at $2.62 on 2025-02-03, raising his holdings to 154,000 shares from 151,000. This marks his 5th open-market buy in ASRV. His prior 4 buys at this ticker all resulted in positive 90-day returns, with 3 exceeding +8.4%, suggesting disciplined entry timing despite volatile near-term price action. The current price of $2.66 is -15.0% from the 52-week high of $3.13, placing this purchase in a depressed part of the recent trading range. However, fundamentals are stressed: the company reported -1.7% annual revenue growth and was unprofitable over its most recent full fiscal year, with market cap of $43.9M. Stopko's consistent pattern of well-timed buys at ASRV contrasts sharply with deteriorating profitability, warranting investigation into whether this reflects conviction in recovery or routine rebalancing aligned with a pre-existing plan.

November 2024
medium
Buy
3,000 shares
$8,550
Significance 6/10

CEO Jeffrey A. Stopko bought 3,000 ASRV shares at $2.85; holdings now 147.2K; prior ASRV buys returned +15.3%, +11.2%, +11.6% over 30 days.

Jeffrey A. Stopko, President & CEO of Ameriserv Financial, purchased 3,000 shares at $2.85 on 2024-11-07, increasing his holdings to 147.2K shares—a modest 2.1% addition to his stake. His prior trades at this ticker show a strong recent pattern: three of the four measurable prior buys delivered substantial 30-day returns of +15.3%, +11.2%, and +11.6%. However, Ameriserv faces near-term headwinds: the company reported a net loss of $-375.0K in the latest quarter, generated only $3.9M in quarterly revenue, and declined 1.7% year-over-year. The 52-week price range of $2.26–$3.28 places the purchase at the lower-middle band, though the stock has risen 6.5% over the past 30 days and 22.0% over 90 days. The CEO's continued accumulation despite recent unprofitability merits monitoring of whether operating performance stabilizes.

August 2024
medium
Buy
2,000 shares
$4,580
Significance 4/10

ASRV CEO buys 2,000 shares at $2.29; stock down 29.6% from 52-week high amid unprofitable quarter

Jeffrey A. Stopko, President & CEO of AMERISERV FINANCIAL INC /PA/, purchased 2,000 shares at $2.29 on 2024-08-13, increasing his holdings from 142,236 shares to 144,236 shares. The purchase occurs at a point where the stock has declined 29.6% from its 52-week high of $3.28 and the company reported a negative net income of $-375,000.00 in its latest quarter with annual revenue growth of -1.7%. While the CEO's open-market history across all tickers shows a 57.14% 90-day win rate with an average 90d return of +3.9%, his timing at ASRV specifically has been mixed—only 1 of 3 prior measurable buys at this ticker delivered positive 90-day returns. The transaction represents a modest addition to an already substantial position (1.4% increase) at depressed levels, but the company's unprofitability and revenue decline warrant investor attention to near-term fundamentals.

medium
Buy
3,047 shares
$7,648
Significance 4/10

ASRV President & CEO Stopko buys 3,047 shares in 2 transactions ($7,647.50) at blended $2.51 avg; stock down 30.7% from 52-week high.

Jeffrey Stopko, President & CEO of AmeriServ Financial, executed 2 separate purchases totaling 3,047 shares for $7,647.50 at prices of $2.50 and $2.51 on August 1-2, 2024, increasing his holdings by 2.2% to 142,236 shares. The timing occurs amid material headwinds: the stock trades at $2.30, down 30.7% from its 52-week high and 4.6% lower over the prior 30 days. At the company level, the most recent full fiscal year was unprofitable, and annual revenue declined 1.7% year-over-year. His prior 5 buys at ASRV show mixed timing outcomes, with only 2 of 5 generating positive 90-day returns, suggesting inconsistent edge in entry selection at this specific ticker. The modest share purchase relative to his existing position and the depressed stock price level warrant observation of whether this represents opportunistic accumulation or a structural signal about management's confidence in a recovery path.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access